Novel Approaches to Seeing & Treating Gliomas for Improved Characterization
Time: 1:45 pm
day: Conference Day 1
Details:
- Highlighting Pixclara® (18F-floretyrosine, 18F-FET) as first-in-class in the US amino acid PET radiotracer for the characterization of progressive or recurrent glioma from treatment related changes in adult and pediatric patients (US NDA under review; approval expected Q2 2025)
- Developing radiopharmaceutical theranostics for Neurooncology targeting LAT-1 receptor in GBM with Betas: TLX-101 (131I iodofalan)
- Developing radiopharmaceutical theranostics for Neurooncology targeting LAT-1 receptor in GBM with Alphas: TLX-102 (211At phenylalanine)
